Tome Biosciences
Watertown, MA
Tome Biosciences is a biotechnology company that develops programmable gene insertion technology. Using CRISPR, its technologies allow them to insert any genetic sequence of any size at any location into any genome.
tome.bioCompany Details
Founded
- 2021
Employees
- Between 50 - 100 employees
Raised
- $213,000,000
Headquarters Location
- Watertown, MA
Public
- No
Acquired
- No
CEO
Mike Lucero
Founders
- Kaveh Daneshvar
Company Collections
These are collections Tome Biosciences is a part of. Click on the collection name to view similar companies.